Adjuvant therapy in gynecologic malignancies: Ovarian, cervical, and endometrial cancer Journal Article


Authors: Curtin, J. P.; Shapiro, F.
Article Title: Adjuvant therapy in gynecologic malignancies: Ovarian, cervical, and endometrial cancer
Abstract: While surgery is the primary treatment for the management of gynecologic malignancies, adjuvant chemotherapy and radiation therapy play a critical role in survival for many patients. In this article, we discuss the feasibility and effectiveness of adjuvant therapy for ovarian, cervical, and endometrial cancers, and discuss current recommendations.
Keywords: cancer survival; treatment outcome; survival rate; review; cisplatin; fluorouracil; multimodality cancer therapy; paclitaxel; chemotherapy, adjuvant; radiotherapy, adjuvant; cancer staging; lymph node metastasis; endometrial neoplasms; lymphatic metastasis; neoplasm staging; ovarian neoplasms; ovary cancer; tumor volume; antineoplastic combined chemotherapy protocols; risk factors; cyclophosphamide; vincristine; risk factor; feasibility studies; uterine cervix cancer; remission induction; brachytherapy; uterus cancer; uterine cervical neoplasms; gynecologic cancer; radical hysterectomy; intravenous drug administration; papanicolaou test; practice guidelines; intraperitoneal drug administration; humans; human; female
Journal Title: Surgical Oncology Clinics of North America
Volume: 6
Issue: 4
ISSN: 1055-3207
Publisher: Elsevier Inc.  
Date Published: 1997-10-01
Start Page: 813
End Page: 830
Language: English
PUBMED: 9309095
PROVIDER: scopus
DOI: 10.1016/S1055-3207(18)30305-3
DOI/URL:
Notes: Review -- Export Date: 17 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. John P Curtin
    112 Curtin
  2. Fred Shapiro
    37 Shapiro
Related MSK Work